Low-Dose Rapamycin Microdepots Promote Hair Regrowth via Autophagy Modulation

    Tiep Tien Nguyen, Trang N. Le, Ngọc Trần Nguyên, Simmyung Yook, Dongryeol Ryu, Gorka Orive, Youngdae Gwon, Jong-Hyuk Sung, Jee‐Heon Jeong
    New to Rapamycin? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary In this study, injectable microdepots containing rapamycin and poly(lactic-co-glycolic acid) were developed and demonstrated to effectively promote hair regrowth in mice by sustaining drug release and inducing anagen phase transition in hair follicles through modulating autophagy and the Wnt/β-catenin pathway.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The study developed low-dose rapamycin microdepots (RAPMD) to promote hair regrowth by modulating autophagy and activating the Wnt/β-catenin pathway. These microdepots, characterized by a 6 μm size and 71% loading efficiency, provided a sustained release of rapamycin over 35 days. In vivo experiments on mice showed that RAPMDs significantly increased hair weight and the number of anagen hair follicles, with the optimal dose being 0.2 µg of RAP equivalent. The research suggests that RAPMDs offer a promising strategy for enhancing hair regrowth in patients with hair loss, highlighting the crucial role of autophagy in hair follicle activation.
    Discuss this study in the Community →

    Research cited in this study

    20 / 20 results